Results 1 to 10 of about 185,168 (287)

Intravenous versus subcutaneous immunoglobulin in patients with haematological malignancies: time-driven activity-based costing. [PDF]

Support Care Cancer
de Albornoz SC, Haysom H, Mo A, Guglielmino J, Dunstan T, Rushford K, Ellison A, Saxby K, Andrew D, Jesurajah A, Banahene P, Hu E, Hoo LS, Petrie D, Wood EM, Higgins AM, McQuilten ZK.   +16 more
europepmc   +1 more source

Activity based costing as tool of controlling [PDF]

У роботі розглянуто метод функціонально-вартісного аналізу, проаналізовано його переваги та недоліки. Запропоновано порівняльний аналіз традиційної системи обліку витрат та функціонально-вартісного аналізу.Abstract considers the activity-based costing ...
Grygorash, Iryna, Григораш, І. О.   +1 more
core   +1 more source

Time-Driven Activity-Based Costing Methodology for Cost Savings in the EMOTE-TNK Study. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Ghosh S, Reyes ID, Vega CP, Yelvington CJ, Worsowicz GM, Boykin O, Huang JF, Christel L, Halstead TM, Mooney LH, Kaplan RS, Franco PM, Freeman WD.   +12 more
europepmc   +1 more source

Is it possible to automate the discovery of process maps for the time-driven activity-based costing method? A systematic review. [PDF]

BMC Health Serv Res, 2023
Iachecen F, Dallagassa MR, Portela Santos EA, Carvalho DR, Ioshii SO.   +4 more
europepmc   +1 more source

A Time-Driven Activity-Based Costing Analysis of Minor Hand Procedure Room Utilization at a Single Military Institution. [PDF]

J Hand Surg Glob Online
Serhan KA, Balazs GC, Lake NH, Henebry A.   +3 more
europepmc   +1 more source

Activity-Based Costing of COVID-19 RT-PCR Testing in Public Laboratories in Indonesia: Evidence for Tariff Setting. [PDF]

Clinicoecon Outcomes Res
Sabarudin S, Alfaqeeh M, Sida NA, Trinovitasari N, Ruslin R, Abushanab D, Wulandari W, Khairinisa MA, Suwantika AA.   +8 more
europepmc   +1 more source

A Time-Driven Activity-Based Costing Analysis of New Uveitis Patient Visits. [PDF]

J Vitreoretin Dis
Berkowitz ST, Finn AP, Thomas AS, Nore L, Akin R, Gangaputra S.   +5 more
europepmc   +1 more source

Provider costs of Antiretroviral therapy (ART) in Zimbabwe: The value of using time-driven activity based costing methods in a low resource setting. [PDF]

PLoS One
Nyamasve JG, Pindiriri C, Mapako T, Ingwani A, Corbin S, Mugurungi O, Apollo T, Chikomo S, Chikambure K, Shamu S, Morrison L, Mujuru N, Boadi E, Peterson T, Chirenda J.   +14 more
europepmc   +1 more source

Een positionering van activity-based costing [PDF]

MAB, 1995
Jan Van De Poel
doaj   +3 more sources